diabetes glp 1 drugs The popularity of GLP-1 has exploded. Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects New Guidelines on GLP-1 Drugs

1 Despite the well-documented risks of UV tanning, a strong societal preference for tanned skin persists

Even without insulin, researchers should have fast-acting carbohydrates available and monitor for symptoms

Recent guidance from endocrinology societies emphasizes the importance of tailoring therapy to individual risk profiles, including cardiovascular and renal considerations

No high-quality clinical trial has demonstrated that B12 injections produce meaningful weight loss outcomes independent of dietary and exercise changes

When phase 3 data pushed retatrutide to 28.7% at the highest dose, the gap widened further

Initial reaction from analysts was muted